logo
episode-header-image
Apr 2021
24m 28s

The Johnson & Johnson Vaccine Pause Expl...

The New York Times
About this episode
Today, science writer Carl Zimmer explains the decision-making process, how long the suspension might last and the impact it could have not only in the U.S. but around the world. Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times. 
Up next
Today
48 Days Until the Midterms: Is a Blue Wave Coming?
As the general midterm elections begin, we take a look at where things stand. A new Times/Siena poll suggests that Democrats have a real shot at winning control of both chambers of Congress. But serious obstacles stand in their way, including a financial disadvantage.The New York ... Show More
36m 46s
Yesterday
The Bond Market Is Flipping Out. Here’s Why You Should Care.
For the past few months, you’ve probably been hearing about the turbulence in the bond market.Today, Ben Casselman, the chief economics correspondent for The New York Times, explains what has been happening, and why it matters.Guest: Ben Casselman, the chief economics corresponde ... Show More
28m 28s
Sep 14
The A.I. Researcher Whose Rebellion Is Changing Everything
In recent days, Jacob Coxon, a researcher at the artificial intelligence company Anthropic, quit his job and posted warnings about the risks of the technology. That kicked off a crisis that culminated in a call by prominent leaders of the industry to slow down A.I. development.He ... Show More
34m 13s
Recommended Episodes
Apr 2021
Halted: Johnson & Johnson & the Vaccination Timeline
After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ... Show More
27m 20s
Apr 2021
Are all viral vector vaccines a problem?
American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ... Show More
11m 14s
Apr 2021
Hitting Pause on the J&J Vaccine
CNN’s Chief Medical Correspondent Dr. Sanjay Gupta walks through what we currently know about the CDC and FDA's decision to pause the use of Johnson & Johnson's Covid-19 vaccine, what this means for people who recently received a J&J shot, and why he isn’t panicking. To learn mor ... Show More
12m 22s
Apr 2021
Coronavirus: How Scary Are the Variants?
UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ... Show More
33m 54s
Apr 2021
J&J It Again, Sam
The CDC and the FDA have lifted their recommended pause on the Johnson and Johnson COVID vaccine, and added a warning label about the very, very rare reported cases of blood clots. But overall vaccination rates in the US are slowing down, indicating that while supply is increasin ... Show More
17m 53s
Apr 2021
VACCINE FACTS: Watch This While You Can ...
The CDC announced it is pausing one of the vaccines due to "blood clots." Which is funny, since Facebook blocks any video that brings up "blood clots." What's up with that? And we know all the riots can blend together, but we'll have the latest on both Derek Chauvin and Daunte Wr ... Show More
1h 18m
Apr 2021
The U.S. Vaccination Rate Continues To Slow
Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities.Have questions about the latest coronavirus ... Show More
11m 15s
Apr 2021
AZ Good as it Gets?
An AstraZeneca vaccine trial on children gets put on pause while a possible link with rare blood clots is investigated. And former Bank of England governor, Mark Carney, talks climate change, fintech and... should Adam sell his Bitcoin? Today’s Newscast was made by Sam Bonham wit ... Show More
32m 39s